Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Common acne treatments can cause various side effects, like skin irritation and more serious issues, but combination therapies are often more effective and better tolerated.

Some plant-derived compounds may help with hormonal conditions, but more research is needed to confirm their effectiveness.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Finasteride and flutamide effectively reduce hirsutism in PCOS women, with flutamide also lowering hormone levels.

Certain hormone treatments can improve acne and related conditions in women.

Isotretinoin effectively reduces acne but causes dry skin, higher skin pH, more redness, and hair loss.

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.

The document concludes that treating PCOS requires a combination of drugs to manage reproductive and metabolic symptoms, with more research needed on combination therapies.

Hair problems are common and distressing for women, but increasing knowledge of treatments offers hope.

Herbal nano-formulations show potential for effective skin delivery but need more research.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Testosterone may help increase sexual events for women with low libido due to antidepressants.

Low-dose flutamide helps reduce excessive hair growth and is even more effective with birth control, without bad effects on blood fats.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

Minoxidil effectively treats female pattern hair loss.

The conclusion is that formalizing how past decisions influence current health technology assessments could improve the credibility and defense of coverage decisions.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Finasteride reduces hair growth and is safe for women with excessive hair.

Excipients greatly affect how well curcumin nanocrystals penetrate the skin and target hair follicles.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.